Avalo Therapeutics Stock (NASDAQ: AVTX) stock price, news, charts, stock research, profile.
Open | $10.180 |
Close | $9.640 |
Volume / Avg. | 24.695K / 676.850K |
Day Range | 9.633 - 10.370 |
52 Wk Range | 3.950 - 1.130K |
Market Cap | $10.951M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 10.09% |
Days to Cover | 1.07 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Avalo Therapeutics (NASDAQ: AVTX) through any online brokerage.
Other companies in Avalo Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Dominari Holdings (NASDAQ:DOMH), Monopar Therapeutics (NASDAQ:MNPR), Addex Therapeutics (NASDAQ:ADXN) and Coeptis Therapeutics (NASDAQ:COEP).
The latest price target for Avalo Therapeutics (NASDAQ: AVTX) was reported by Oppenheimer on Tuesday, April 16, 2024. The analyst firm set a price target for 35.00 expecting AVTX to rise to within 12 months (a possible 230.50% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Avalo Therapeutics (NASDAQ: AVTX) is $10.59 last updated Today at May 16, 2024 at 7:26 AM EDT.
There are no upcoming dividends for Avalo Therapeutics.
Avalo Therapeutics’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Avalo Therapeutics.
Avalo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.